Functional exhaustion of antiviral lymphocytes in COVID-19 patients

A novel coronavirus from patients with pneumonia in China, 2019

Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244 · see citing works

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969 · see citing works

Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415 · see citing works

Restoring function in exhausted CD8 T cells during chronic viral infection

Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2005) · Nature · doi:10.1038/nature04444 · Cited by 3,960 · see citing works

Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells

André, P., Denis, C., Soulas, C., Bourbon, C., Lopez, J., Arnoux, T., Bléry, M., Bonnafous, C., Gauthier, L., Morel, A., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.014 · Cited by 1,229 · see citing works

Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity

Zhang, Q., Bi, J., Zheng, X., Chen, Y., Wang, H., Wu, W., Wang, Z., Wu, Q., Peng, H. C., Wei, H., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0132-0 · Cited by 1,121 · see citing works

Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice

Li, F., Wei, H., Wei, H., Gao, Y., Xu, L., Yin, W., Sun, R., & Tian, Z. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.10.039 · Cited by 164 · see citing works

NKG2A is a NK cell exhaustion checkpoint for HCV persistence

Zhang, C., Wang, X., Li, S.-R., Twelkmeyer, T., Wang, W., Zhang, S.-Y., Wang, S., Chen, J., Jin, X., Wu, Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09212-y · Cited by 143 · see citing works

NKG2A, a New Kid on the Immune Checkpoint Block

Haanen, J. B. A. G., & Cerundolo, V. (2018) · Cell · doi:10.1016/j.cell.2018.11.048 · Cited by 104 · see citing works

Viral Persistence and Chronicity in Hepatitis C Virus Infection: Role of T-Cell Apoptosis, Senescence and Exhaustion

Barathan, M., Mohamed, R., Yong, Y. K., Kannan, M., Vadivelu, J., Saeidi, A., Larsson, M., & Shankar, E. M. (2018) · Cells · doi:10.3390/cells7100165 · Cited by 38 · see citing works

COVID-19 pathophysiology: A review

Yuki, K., Shibamura‐Fujiogi, M., & Koutsogiannaki, S. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108427 · Cited by 2,217 · see citing works

Cytokine release syndrome in severe COVID-19

Moore, J. B., & June, C. H. (2020) · Science · doi:10.1126/science.abb8925 · Cited by 1,912 · see citing works

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.017 · Cited by 1,788 · see citing works

The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease

McGonagle, D., Sharif, K., O'Regan, A., & Bridgewood, C. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102537 · Cited by 1,654 · see citing works

COVID-19: immunopathology and its implications for therapy

Cao, X. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0308-3 · Cited by 1,609 · see citing works

Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications

Mathew, D., Giles, J. R., Baxter, A. E., Oldridge, D. A., Greenplate, A. R., Wu, J. E., Alanio, C., Kuri-Cervantes, L., Pampena, M. B., D’Andrea, K., et al. (2020) · Science · doi:10.1126/science.abc8511 · Cited by 1,509 · see citing works

Immunology of COVID-19: Current State of the Science

Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623 · see citing works

Targeting potential drivers of COVID-19: Neutrophil extracellular traps

Barnes, B. J., Adrover, J. M., Baxter-Stoltzfus, A., Borczuk, A., Cools-Lartigue, J., Crawford, J. M., Daßler-Plenker, J., Guerci, P., Huynh, C., Knight, J. S., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20200652 · Cited by 1,486 · see citing works

Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans

Arunachalam, P. S., Wimmers, F., Mok, C. K. P., Perera, R. A. P. M., Scott, M., Hagan, T., Sigal, N., Feng, Y., Bristow, L., Tak-Yin Tsang, O., et al. (2020) · Science · doi:10.1126/science.abc6261 · Cited by 1,186 · see citing works

Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies

Tang, Y., Liu, J., Zhang, D., Xu, Z., Ji, J., & Wen, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01708 · Cited by 1,094 · see citing works

Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19

Azkur, A. K., Akdiş, M., Azkur, D., Sokołowska, M., van de Veen, W., Brüggen, M., O’Mahony, L., Gao, Y., Nadeau, K. C., & Akdiş, C. A. (2020) · Allergy · doi:10.1111/all.14364 · Cited by 1,117 · see citing works

Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis

Mao, R., Qiu, Y., He, J.-S., Tan, J.-Y., Li, X.-H., Liang, J., Shen, J., Zhu, L.-R., Chen, Y., Iacucci, M., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30126-6 · Cited by 1,056 · see citing works

Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases

Buonacera, A., Stancanelli, B., Colaci, M., & Malatino, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073636 · Cited by 1,083 · see citing works

A dynamic COVID-19 immune signature includes associations with poor prognosis

Laing, A. G., Lorenc, A., del Molino del Barrio, I., Das, A., Fish, M., Monin, L., Muñoz-Ruiz, M., McKenzie, D. R., Hayday, T. S., Francos-Quijorna, I., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1038-6 · Cited by 946 · see citing works

COVID-19: immunopathogenesis and Immunotherapeutics

Li, Y., Liu, S., Liu, J., Zhang, Z., Wan, X., Huang, B., Chen, Y., & Zhang, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00243-2 · Cited by 923 · see citing works

Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis

Codo, A. C., Davanzo, G. G., Monteiro, L. D. B., de Souza, G. F., Muraro, S. P., Virgílio-da-Silva, J. V., Prodonoff, J. S., Carregari, V. C., de Biagi, C. A. O., Crunfli, F., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.07.007 · Cited by 908 · see citing works

Biomarkers associated with COVID-19 disease progression

Ponti, G., Maccaferri, M., Ruini, C., Tomasi, A., & Özben, T. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1770685 · Cited by 902 · see citing works

Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms

Proal, A. D., & VanElzakker, M. B. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.698169 · Cited by 894 · see citing works

Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia

De Biasi, S., Meschiari, M., Gibellini, L., Bellinazzi, C., Borella, R., Fidanza, L., Gozzi, L., Iannone, A., Lo Tartaro, D., Mattioli, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17292-4 · Cited by 789 · see citing works

Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19

Lee, J. S., Park, S.-W., Jeong, H. W., Ahn, J. Y., Choi, S. J., Lee, H., Choi, B., Nam, S. K., Sa, M., Kwon, J., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd1554 · Cited by 805 · see citing works

COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment

Parasher, A. (2020) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-138577 · Cited by 780 · see citing works

COVID-19 and the human innate immune system

Schultze, J. L., & Aschenbrenner, A. C. (2021) · Cell · doi:10.1016/j.cell.2021.02.029 · Cited by 714 · see citing works

T cell responses in patients with COVID-19

Chen, Z., & John Wherry, E. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0402-6 · Cited by 797 · see citing works

Immune response, inflammation, and the clinical spectrum of COVID-19

García, L. F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01441 · Cited by 739 · see citing works

Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

Su, Y., Chen, D., Yuan, D., Lausted, C. G., Choi, J., Dai, C. L., Voillet, V., Duvvuri, V. R. S. K., Scherler, K., Troisch, P., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.037 · Cited by 591 · see citing works

The signal pathways and treatment of cytokine storm in COVID-19

Yang, L., Xie, X., Tu, Z., Fu, J., Xu, D., & Zhou, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00679-0 · Cited by 599 · see citing works

Immunity, endothelial injury and complement-induced coagulopathy in COVID-19

Perico, L., Benigni, A., Casiraghi, F., Ng, L. F. P., Rénia, L., & Remuzzi, G. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00357-4 · Cited by 603 · see citing works

SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients

Geers, D., Shamier, M. C., Bogers, S., den Hartog, G., Gommers, L., Nieuwkoop, N. N., Schmitz, K. S., Rijsbergen, L. C., van Osch, J. A. T., Dijkhuizen, E., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abj1750 · Cited by 529 · see citing works

SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates

Poland, G., Ovsyannikova, I., & Kennedy, R. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32137-1 · Cited by 540 · see citing works

Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis

Carvelli, J., Demaria, O., Vély, F., Batista, L., Chouaki Benmansour, N., Fares, J., Carpentier, S., Thibult, M.-L., Morel, A., Remark, R., et al. (2020) · Nature · doi:10.1038/s41586-020-2600-6 · Cited by 526 · see citing works

Immunopathology of Hyperinflammation in COVID-19

Gustine, J. N., & Jones, D. (2021) · The American Journal of Pathology · doi:10.1016/j.ajpath.2020.08.009 · Cited by 516 · see citing works

Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?

Bajaj, V., Gadi, N., Spihlman, A. P., Wu, S. C., Choi, C. H., & Moulton, V. R. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.571416 · Cited by 476 · see citing works

Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis

Zhao, Q., Meng, M., Kumar, R., Wu, Y., Huang, J., Deng, Y., Weng, Z., & Yang, L. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.04.086 · Cited by 503 · see citing works

Biochemical characterization of SARS-CoV-2 nucleocapsid protein

Zeng, W., Liu, G., Ma, H., Zhao, D., Yang, Y., Liu, M., Mohammed, A., Zhao, C., Yang, Y., Xie, J., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.04.136 · Cited by 480 · see citing works

Dysregulation of type I interferon responses in COVID-19

Acharya, D., Liu, G., & Gack, M. U. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0346-x · Cited by 454 · see citing works

Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience

Bryce, C., Grimes, Z., Pujadas, E., Ahuja, S., Beasley, M. B., Albrecht, R. A., Hernandez, T., Stock, A., Zhao, Z., AlRasheed, M. R., et al. (2021) · Modern Pathology · doi:10.1038/s41379-021-00793-y · Cited by 412 · see citing works

Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China

Chen, R., Sang, L., Jiang, M., Yang, Z., Jia, N., Fu, W., Xie, J., Guan, W., Liang, W., Ni, Z., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.003 · Cited by 376 · see citing works

Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines

Fara, A. F., Mitrev, Z. K., Rosalia, R. A., & Assas, M. B. (2020) · Open Biology · doi:10.1098/rsob.200160 · Cited by 368 · see citing works

Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19

Bernardes, J. P., Mishra, N., Tran, F., Bahmer, T., Best, L., Blase, J. I., Bordoni, D., Franzenburg, J., Geisen, U., Josephs-Spaulding, J., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.11.017 · Cited by 322 · see citing works

Detection of COVID-19 Infection from Routine Blood Exams with Machine Learning: A Feasibility Study

Brinati, D., Campagner, A., Ferrari, D., Locatelli, M., Banfi, G., & Cabitza, F. (2020) · Journal of Medical Systems · doi:10.1007/s10916-020-01597-4 · Cited by 365 · see citing works

Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover

Soresina, A., Moratto, D., Chiarini, M., Paolillo, C., Baresi, G., Focà, E., Bezzi, M., Baronio, B., Giacomelli, M., & Badolato, R. (2020) · Pediatric Allergy and Immunology · doi:10.1111/pai.13263 · Cited by 327 · see citing works

COVID-19: towards understanding of pathogenesis

Cao, W., & Li, T. (2020) · Cell Research · doi:10.1038/s41422-020-0327-4 · Cited by 344 · see citing works

COVID-19 and the Immune System

Pačes, J., Strizova, Z. O., Smrž, D., & Černý, J. (2020) · Physiological Research · doi:10.33549/physiolres.934492 · Cited by 350 · see citing works

Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection

Liang, Y., Wang, M., Chien, C., Yarmishyn, A. A., Yang, Y.-P., Lai, W.-Y., Luo, Y., Lin, Y.-T., Chen, Y.-J., Chang, P., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01022 · Cited by 339 · see citing works

Lymphopenia in COVID‐19: Therapeutic opportunities

Fathi, N., & Rezaei, N. (2020) · Cell Biology International · doi:10.1002/cbin.11403 · Cited by 324 · see citing works

Autoinflammatory and autoimmune conditions at the crossroad of COVID-19

Rodríguez, Y., Novelli, L., Rojas, M., Santis, M. D., Acosta‐Ampudia, Y., Monsalve, D. M., Ramı́rez-Santana, C., Costanzo, A., Ridgway, W. M., Ansari, A. A., et al. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102506 · Cited by 312 · see citing works

Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections

Remy, K. E., Mazer, M. B., Striker, D. A., Ellebedy, A. H., Walton, A. H., Unsinger, J., Blood, T. M., Mudd, P. A., Yi, D. J., Mannion, D. A., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.140329 · Cited by 309 · see citing works

COVID-19 and Solid Organ Transplantation: A Review Article

Azzi, Y., Bartash, R. M., Scalea, J. R., Loarte-Campos, P., & Akalin, E. (2020) · Transplantation · doi:10.1097/tp.0000000000003523 · Cited by 304 · see citing works

Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy

Ciceri, F., Castagna, A., Rovere, P. Q., COBELLI, F. D., Ruggeri, A., Galli, L., Conte, C., LORENZO, R. D., Poli, A., Ambrosio, A. G., et al. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108509 · Cited by 294 · see citing works

The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of “inflame-aging”

Meftahi, G. H., Jangravi, Z., Sahraei, H., & Bahari, Z. (2020) · Inflammation Research · doi:10.1007/s00011-020-01372-8 · Cited by 289 · see citing works

The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies

Frederiksen, L. S. F., Zhang, Y., Foged, C., & Thakur, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01817 · Cited by 289 · see citing works

COVID-19 and Cancer: a Comprehensive Review

Gosain, R., Abdou, Y. G., Singh, A., Rana, N. K., Puzanov, I. J., & Ernstoff, M. S. (2020) · Current Oncology Reports · doi:10.1007/s11912-020-00934-7 · Cited by 286 · see citing works

Current status of potential therapeutic candidates for the COVID-19 crisis

Zhang, J., Xie, B., & Hashimoto, K. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.04.046 · Cited by 282 · see citing works

Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial

Shi, L., Huang, H., Lu, X.-C., Yan, X., Jiang, X., Xu, R., Wang, S., Zhang, C., Yuan, X., Xu, Z., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00488-5 · Cited by 277 · see citing works

Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2

Salamanna, F., Maglio, M., Landini, M. P., & Fini, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.594495 · Cited by 283 · see citing works

Two distinct immunopathological profiles in autopsy lungs of COVID-19

Nienhold, R., Ciani, Y., Koelzer, V. H., Tzankov, A., Haslbauer, J. D., Menter, T., Schwab, N., Henkel, M., Frank, A., Zsikla, V., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18854-2 · Cited by 246 · see citing works

Unique immunological profile in patients with COVID-19

Varchetta, S., Mele, D., Oliviero, B., Mantovani, S., Ludovisi, S., Cerino, A., Bruno, R., Castelli, A., Mosconi, M., Vecchia, M., et al. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00557-9 · Cited by 274 · see citing works

COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions?

Arastehfar, A. A., Carvalho, A., Nguyen, M. H., Hedayati, M. T., Netea, M. G., Perlin, D. S., & Hoenigl, M. (2020) · Journal of Fungi · doi:10.3390/jof6040211 · Cited by 272 · see citing works

Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19Preprint

Sekine, T., Perez‐Potti, A., Rivera‐Ballesteros, O., Strålin, K., Gorin, J., Olsson, A., Llewellyn‐Lacey, S., Kamal, H., Bogdanović, G., Muschiol, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.29.174888 · Cited by 272 · see citing works

Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells

Witkowski, M., Tizian, C., Ferreira‐Gomes, M., Niemeyer, D., Jones, T. C., Heinrich, F., Frischbutter, S., Angermair, S., Hohnstein, T., Mattiola, I., et al. (2021) · Nature · doi:10.1038/s41586-021-04142-6 · Cited by 247 · see citing works

COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes

Sánchez‐Cerrillo, I., Landete, P., Orzaiz, B. A., Sánchez‐Alonso, S., Sánchez-Azofra, A., Marcos‐Jiménez, A., Ávalos, E., Alcaraz‐Serna, A., Santos, I. D. L., Mateu‐Albero, T., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci140335 · Cited by 250 · see citing works

Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19

Guo, Q., Zhao, Y., Li, J., Liu, J., Yang, X., Guo, X., Kuang, M., Xia, H., Zhang, Z., Cao, L., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.12.016 · Cited by 249 · see citing works

Chemokines and chemokine receptors during COVID-19 infection

Khalil, B. A., Elemam, N. M., & Maghazachi, A. A. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.01.034 · Cited by 246 · see citing works

Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response

Cunha, L. L., Perazzio, S. F., Azzi, J., Cravedi, P., & Riella, L. V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01748 · Cited by 239 · see citing works

COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients

Belsky, J. A., Tullius, B. P., Lamb, M. G., Sayegh, R., Stanek, J. R., & Auletta, J. J. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.01.022 · Cited by 239 · see citing works

Deciphering the COVID‐19 cytokine storm: Systematic review and meta‐analysis

Mulchandani, R., Lyngdoh, T., & Kakkar, A. K. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13429 · Cited by 242 · see citing works

Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19

Ramakrishnan, R. K., Kashour, T., Hamid, Q. A., Halwani, R., & Tleyjeh, I. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.686029 · Cited by 240 · see citing works

Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers

Luo, J., Rizvi, H. A., Egger, J. V., Preeshagul, I. R., Wolchok, J. D., & Hellmann, M. D. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0596 · Cited by 234 · see citing works

Baricitinib: A Review of Pharmacology, Safety, and Emerging Clinical Experience in COVID‐19

Jorgensen, S. C. J., Tse, C. L. Y., Burry, L. D., & Dresser, L. (2020) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2438 · Cited by 227 · see citing works

PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19

Rha, M., Jeong, H. W., Ko, J. H., Choi, S. J., Seo, I., Lee, J. S., Sa, M., Kim, A. R., Joo, E., Ahn, J. Y., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.12.002 · Cited by 221 · see citing works

The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19?

McKechnie, J. L., & Blish, C. A. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.05.009 · Cited by 218 · see citing works

Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management

Chavda, V. P., Vora, L. K., Pandya, A., & Patravale, V. B. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.07.021 · Cited by 212 · see citing works

The Immune Response and Immunopathology of COVID-19

Mortaz, E., Tabarsi, P., Varahram, M., Folkerts, G., & Adcock, I. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02037 · Cited by 206 · see citing works

T‐cell responses and therapies against SARS‐CoV‐2 infection

Toor, S. M., Saleh, R., Nair, V. S., Taha, R. Z., & Elkord, E. (2020) · Immunology · doi:10.1111/imm.13262 · Cited by 204 · see citing works

COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects

Smadja, D. M., Mentzer, S. J., Fontenay, M., Laffan, M., Ackermann, M., Helms, J., Jonigk, D. D., Chocron, R., Pier, G. B., Gendron, N., et al. (2021) · Angiogenesis · doi:10.1007/s10456-021-09805-6 · Cited by 200 · see citing works

Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases

Carsetti, R., Zaffina, S., Mortari, E. P., Terreri, S., Corrente, F., Capponi, C., Palomba, P., Mirabella, M., Cascioli, S., Palange, P., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.610300 · Cited by 195 · see citing works

Activation or exhaustion of CD8+ T cells in patients with COVID-19

Rha, M., & Shin, E. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00750-4 · Cited by 193 · see citing works

Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses — are we our own worst enemy?

Wong, L.-Y. R., & Perlman, S. M. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00656-2 · Cited by 196 · see citing works

Viral persistence, reactivation, and mechanisms of long COVID

Chen, B. K., Jülg, B. D., Mohandas, S., Bradfute, S. B., & RECOVER Mechanistic Pathways Task Force (2023) · eLife · doi:10.7554/elife.86015 · Cited by 192 · see citing works

Could there be a link between oral hygiene and the severity of SARS-CoV-2 infections?

Sampson, V., Kamona, N., & Sampson, A. (2020) · BDJ · doi:10.1038/s41415-020-1747-8 · Cited by 205 · see citing works

The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19

Callender, L. A., Curran, M., Bates, S. M., Mairesse, M., Weigandt, J., & Betts, C. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01991 · Cited by 190 · see citing works

What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses

Gadi, N., Wu, S., Spihlman, A. P., & Moulton, V. R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02147 · Cited by 185 · see citing works

T Cells: Warriors of SARS-CoV-2 Infection

de Candia, P., Prattichizzo, F., Garavelli, S., & Matarese, G. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.11.002 · Cited by 186 · see citing works

Innate immunological pathways in COVID-19 pathogenesis

Paludan, S. R., & Mogensen, T. H. (2022) · Science Immunology · doi:10.1126/sciimmunol.abm5505 · Cited by 186 · see citing works

Selenium and selenoproteins in viral infection with potential relevance to COVID-19

Zhang, J., Saad, R., Taylor, E. W., & Rayman, M. P. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101715 · Cited by 185 · see citing works

I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People

Pietrobon, A. J., Teixeira, F. M. E., & Sato, M. N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.579220 · Cited by 185 · see citing works

Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid

Heming, M., Li, X., Räuber, S. J., Mausberg, A. K., Börsch, A., Hartlehnert, M., Singhal, A., Lu, I., Fleischer, M., Szepanowski, F., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.12.011 · Cited by 179 · see citing works

Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action?

Islam, H., Chamberlain, T. C., Mui, A., & Little, J. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.677008 · Cited by 183 · see citing works

Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity

Hoagland, D. A., Møller, R., Uhl, S. A., Oishi, K., Frere, J. J., Golynker, I., Horiuchi, S., Panis, M., Blanco-Melo, D., Sachs, D. M., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.01.017 · Cited by 170 · see citing works

Natural Killer Cell Dysfunction and Its Role in COVID-19

van Eeden, C., Khan, L., Osman, M. S., & Tervaert, J. W. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176351 · Cited by 172 · see citing works

Rethinking the role of hydroxychloroquine in the treatment of COVID‐19

Meyerowitz, E. A., Vannier, A., Friesen, M. G. N., Schoenfeld, S. R., Gelfand, J. A., Callahan, M. V., Kim, A. Y., Reeves, P. M., & Poznansky, M. C. (2020) · The FASEB Journal · doi:10.1096/fj.202000919 · Cited by 174 · see citing works

Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19

Rogero, M., Leão, M. D. C., Santana, T. M., Pimentel, M. V. D. M. B., Carlini, G. C., Silveira, T. F. D. D., Gonçalves, R. C., & Castro, I. A. (2020) · Free Radical Biology & Medicine · doi:10.1016/j.freeradbiomed.2020.07.005 · Cited by 293 · see citing works

Is pregnancy a risk factor of COVID-19?

Phoswa, W. N., & Khaliq, O. P. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.06.058 · Cited by 173 · see citing works

Immunology of COVID‐19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI)

Sokołowska, M., Łukasik, Z. M., Agache, I. O., Akdiş, C. A., Akdiş, D., Akdiş, M., Barcik, W., Brough, H. A., Eiwegger, T., Eljaszewicz, A., et al. (2020) · Allergy · doi:10.1111/all.14462 · Cited by 169 · see citing works

Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China

Wu, H., Zhu, H., Yuan, C., Yao, C., Luo, W. P., Shen, X., Wang, J., Shao, J., & Xiang, Y. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.10895 · Cited by 168 · see citing works

Microstructure, pathophysiology, and potential therapeutics of COVID‐19: A comprehensive review

Singh, S. P., Pritam, M., Pandey, B., & Yadav, T. P. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26254 · Cited by 166 · see citing works

Long COVID and the cardiovascular system—elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases

Gyöngyösi, M., Alcaide, P., Asselbergs, F. W., Brundel, B. J. J. M., Camici, G. G., Martins, P. A. D. C., Ferdinandy, P., Fontana, M., Girão, H., Gnecchi, M., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac115 · Cited by 167 · see citing works

Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals

Gong, F., Dai, Y., Zheng, T., Cheng, L., Zhao, D., Wang, H., Liu, M., Pei, H., Jin, T., Yu, D., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci141054 · Cited by 160 · see citing works

Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients

Zheng, H.-Y., Zhang, M., Yang, C.-X., Zhang, N., Wang, X.-C., Yang, X.-P., Dong, X.-Q., & Zheng, Y.-T. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0401-3 · Cited by 940 · see citing works

Natural killer cell exhaustion in SARS-CoV-2 infection

Gallardo‐Zapata, J., & Maldonado‐Bernal, C. (2022) · Innate Immunity · doi:10.1177/17534259221077750 · Cited by 18 · see citing works

Convalescent donor SARS‐COV‐2‐specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID‐19 patients with severe disease has not received enough attention till date

Hanley, B. P., Roufosse, C. A., Osborn, M., & Naresh, K. N. (2020) · British Journal of Haematology · doi:10.1111/bjh.16780 · Cited by 11 · see citing works

A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)

Mohammed, R. N., Tamjidifar, R., Rahman, H. S., Adili, A., Ghoreishizadeh, S., Saeedi, H., Thangavelu, L. P., Shomali, N., Aslaminabad, R., Marofi, F., et al. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00856-w · Cited by 53 · see citing works

How Lymphocytes Kill

Young, L. (1990) · Annual Review of Medicine · doi:10.1146/annurev.med.41.1.45